We use cookies for a better user experience. Read our Privacy Policy

I Agree

Syphilis Immunoassay Diagnostics Market

Syphilis Immunoassay Diagnostics Market (Product: Analyzers, Kits & Reagents; Technology: ELISA, CLIA, Others; End User: Hospitals, Diagnostic Labs, Blood Banks, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Advanced Analyzers Provide High-quality Solutions in Syphilis Immunoassay Diagnostics

New innovations in syphilis analyzers are becoming increasingly mainstream in the syphilis immunoassay diagnostics market. As such, companies are launching new technologies in analyzers. For instance, in April 2019, Gold Standard Diagnostics - a provider of comprehensive diagnostic solutions, revealed the launch of its proprietary technology with a U.S. patent, which performs serological testing for syphilis.

Advancements in analyzer technologies are creating incremental opportunities for healthcare companies in the syphilis immunoassay diagnostics market space. There is increasing demand for advanced analyzers in hospitals and blood banks due to increase in the spending capacity of patients with STDs. Companies in the syphilis immunoassay diagnostics market are innovating in new technologies with the help of dedicated machines to automate rapid plasma regain (RPR) assays. They are improving testing capabilities for laboratories with the help of new software developments to enhance outcomes in patients.

Novel approaches of technological automation and machine learning are being adopted to develop first-of-its-kind diagnostics systems. The combination of approaches is helping clinical laboratories offer high-quality solutions for syphilis testing.

syphilis immunoassay diagnostics market infographic

To know the scope of our report Get a Sample on Syphilis Immunoassay Diagnostics Market

On-the-spot Testing Solutions Help Perform Immunoassays in ELISA

The growing trend of on-the-spot testing solutions has led to improvements in the syphilis immunoassay diagnostics landscape. For instance, clinical diagnostics company MBio, announced the launch of the LightDeck® platform, an innovative analytical technology that performs quantitative immunoassays and cell based assays. With the help of on-the-spot testing, companies in the syphilis immunoassay diagnostics market can tap into new business models, such as providing analytical testing services to the veterinary, food, military sectors.

Companies in the syphilis immunoassay diagnostics market are focused on expanding their product portfolios. They are increasing efforts to manufacture and sell instruments by acquiring licensing for the same. By these efforts, they are supporting the global OEM supply business model associated with various assays and their applications.

Healthcare industries are developing multiplexed immunoassay systems by experimenting on planar waveguide technology and fluorescence imaging. These efforts are being made to support outcomes in the ELISA (enzyme-linked immunosorbent assay) test, since ELISA currently accounts for the highest revenue in the syphilis immunoassay diagnostics market.

Get a glimpse of the in-depth analysis through our Report Brochure

PCR Gains Popularity as Non-invasive Specimen for Effective Diagnosis of Syphilis

Recent advancements in molecular biology have led to the popularity of molecular diagnosis, such as the polymerase chain reaction (PCR), in the syphilis immunoassay diagnostics ecosystem. PCR technology is playing a crucial role in diagnosing syphilis. Healthcare industries in the syphilis immunoassay diagnostics market are developing various PCR methodologies that can be easily adapted in the clinical and laboratory environment. PCR is being increasingly associated with widespread application and deep exploration in the healthcare space.

Fast developments in PCR have led to advancements in real-time PCR, nested PCR, and multiplex PCR. The high sensitivity and specificity of PCR is well-suited for the diagnosis of early-stage syphilis. On the other hand, routine PCR is well-received in secondary syphilis. Healthcare companies in the syphilis immunoassay diagnostics market are increasing R&D to detect atypical cases of vertebral, ocular, and tonsillar syphilis with the help of molecular biology. Real-time PCR is gaining increased popularity for its ability to calculate the sum of pathogens that reveal the severity of the infection.

Companies Improve Access to Testing Technologies in LMICs to Prevent Maternal Syphilis

The issue of maternal and child mortality due to syphilis and HIV/AIDS is distinctly prevalent in low- and middle-income countries (LMICs). This is why, healthcare industries in the syphilis immunoassay diagnostics market are increasing efforts to improve child and maternal health through antenatal care.

At the same time, companies in the syphilis immunoassay diagnostics space are innovating in point of care diagnostic services. Although healthcare industries are making progress in the prevention of mother-to-child transmission, several new cases of pediatric infections are still being reported. Thus, companies in the syphilis immunoassay diagnostics market should improve access to new testing technologies that will reduce the incidence of syphilis infection in LMICs. Along with testing for syphilis, companies should offer convenient testing options such as the dual HIV/syphilis rapid diagnostics test to help patients assess the prevalence of any other bacterial infections.

Companies in the syphilis immunoassay diagnostics ecosystem are also increasing the availability of antenatal rapid syphilis testing in LMICs. Undiagnosed and untreated maternal syphilis has catalyzed the demand for antenatal rapid syphilis testing.

syphilis immunoassay diagnostics market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

Kits and reagents are projected for high growth in the syphilis immunoassay diagnostics market. Apart from manual testing, healthcare companies are turning toward automating high-quality syphilis test kits with the use of state-of-the-art machines. FDA-cleared automated analyzers are also triggering market growth.

Healthcare providers are increasingly replacing labor-intensive reading with full automatic results that meet the 'results-per-hour' demand. However, the transmission of syphilis during blood donation poses a huge risk for healthcare providers. Hence, companies should educate healthcare providers about thorough health consultation and screening of high-risk groups before blood donation. Companies should invest in developing robust clinical chemistry analyzers that provide automation-ready immunoassays.

Syphilis Immunoassay Diagnostics Market and Report Description

  • Syphilis is a sexually transmitted disease caused by a bacteria called Treponema pallidum. The most common route of transmission is through contact with an infected person’s sore during sexual activity. The syphilis immunoassay diagnostics market is likely to expand significantly, as syphilis continues to be a global concern.
  • Syphilis immunoassay diagnostic tests are vital to ascertain an infection. According to CDC and IUSTI guidelines, blood serological tests for syphilis remain the diagnostic standard. At least one treponemal antigen test (syphilis immunoassay diagnostics) and one non-treponemal antigen test is sufficient to confirm syphilis.
  • The global syphilis immunoassay diagnostics market was valued at ~US$ 310 Mn in 2018, and is projected to reach ~US$ 380 Mn by 2027.
  • The global syphilis immunoassay diagnostics market is projected to expand at a CAGR of ~2% during the forecast period of 2019 to 2027.

Syphilis Immunoassay Diagnostics Market: Drivers

  • Sexually transmitted diseases (STDs) have reached become an epidemic across the world. According to 2016 World Health Organizations (WHO) research findings, more than 1 million people acquire sexually transmitted infections (STI), every day, globally.
  • Research findings also suggest that, every year, 350 million new cases of one of four (chlamydia, gonorrhea, syphilis, and trichomoniasis) curable sexually transmitted infections (STIs) occur each year, and out of that, 6 million new cases are found. This is estimated to offer significant opportunities to the syphilis immunoassay diagnostic market.
  • Mother-to-child and gestational syphilis is a global concern, and affects more than 1 million pregnant women, globally. This is likely to drive the demand for syphilis immunoassay diagnostics.
  • Syphilis is primarily transmitted through sexual activity, and it remains a significant public health issue, worldwide. STDs are caused due to social, economic, and biological factors. STDs disproportionately affect disenfranchised people and people in social networks, in which high-risk sexual behavior is commonly observed, especially when either access to healthcare or health-seeking behavior is compromised. Therefore, socioeconomic factors are also likely to boost the global syphilis immunoassay diagnostic market.

Global Syphilis Immunoassay Diagnostics Market: Key Segments

  • The global syphilis immunoassay diagnostics market has been bifurcated into product, technology, and end user.
  • Increasing number of tests and one time uses of reagents are projected to boost the demand for kits & reagents at a high CAGR in the syphilis immunoassay diagnostics market.
  • In terms of end user, diagnostic labs held a dominant share of the global syphilis immunoassay diagnostic market; however, mandatory tests of blood donors is boosting the blood banks segment across the globe.
  • Higher efficiency of CLIA technology and low turnaround time as compared to that offered by ELISA technology are projected to drive the demand for CLIA technology in the syphilis immunoassay diagnostics market during the forecast period.

Global Syphilis Immunoassay Diagnostics Market: Trends

  • Preparing reagents for testing is a time-consuming job. Ready-to-use reagents offer several advantages as compared to that offered by preparing reagents.
  • Ready-to use reagents avoid wastage of time taken for dilutions, calculation, pipetting, and prevents contamination. So, the demand for these reagents is high in hospitals and clinical laboratories, thereby boosting the syphilis immunoassay diagnostics market.
  • Moreover, technological advancements are closing the gaps for effective diagnosis by providing better diagnostics procedures. Hospitals and labs in emerging economies in Asia Pacific are able to carry larger number of tests for syphilis through advanced analyzers and offer proper treatment options to eradicate syphilis infection. For instance, in June 2016, Thailand became the first country in Asia to eliminate mother-to-child transmission of syphilis, after it successfully reduced transmission rates to less than 2%.
  • These factors are having a positive effect on the growth of the syphilis immunoassay diagnostics landscape.

Global Syphilis Immunoassay Diagnostics Market: Major Players

  • Key players analyzed in this report on the syphilis immunoassay diagnostics market are -
    • Bio-Rad Laboratories, Inc.
    • Danaher (Beckman Coulter, Inc.)
    • Becton
    • Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • DiaSorin S.p.A.
    • Abbott Laboratories
    • Ortho Clinical Diagnostics (a part of Carlyle Group)
    • Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • bioMérieux SA
    • Fujirebio (Miraca Group)
  • Strategic mergers & acquisitions, new product launches, and emphasis on research & development are key strategies adopted by major players in the global syphilis immunoassay diagnostics market.
  • On October 03, 2017, Abbott announced the acquisition of Alere Inc., a provider of diagnostic devices and services, for nearly US$ 5,300.0 Mn.
  • In June 2017, Bio-Rad Laboratories, Inc. received FDA approval for its BioPlex 2200 syphilis total & RPR assay, a novel testing method for the diagnosis of syphilis infection.
  • Major players in the syphilis immunoassay diagnostics market such as Abbott, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, and DiaSorin S.p.A. hold more than 50% share of the global syphilis immunoassay diagnostics market.

Global Syphilis Immunoassay Diagnostics Market - Segmentation

TMR’s study on the global syphilis immunoassay diagnostics market includes information divided into four sections - by product, by technology, by end user, and by region. Changing industry trends and other crucial market dynamics associated with these sections of the global syphilis immunoassay diagnostics market have been discussed in detail.

Product

  • Analyzers
  • Kits & Reagents

Technology

  • ELISA
  • CLIA
  • Others

End User

  • Hospitals  
  • Diagnostic Labs
  • Blood Banks
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of syphilis immunoassay diagnostics market?

Syphilis immunoassay diagnostics market is projected to reach ~US$ 380 Mn by 2027

What is the anticipated CAGR of the syphilis immunoassay diagnostics market in the forecast period?

Syphilis immunoassay diagnostics market is projected to expand at a CAGR of ~2% during 2019 - 2027

What are the key driving factors for the growth of the syphilis immunoassay diagnostics market?

Syphilis immunoassay diagnostics market is driven by increase in prevalence of HIV infections across the globe

Which is the rising prominent segment in the syphilis immunoassay diagnostics market?

The chemiluminescence immunoassay (CLIA) segment segment dominated the global syphilis immunoassay diagnostics market

Who are the key players in the global syphilis immunoassay diagnostics market?

Key players in the global syphilis immunoassay market include Bio Rad Laboratories, Inc., Becton, F. Hoffmann la Roche Ltd., DiaSorin S.p.A., Ortho Clinical Diagnostics (part of the Carlyle Group)

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Class Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Technological Advancement

    5.2. Key Merger & Acquisition

    5.3. Top Three Players- Analysis

    5.4. Number of Syphilis Diagnostic Test, by Technology (2018)

    5.5. Pricing Analysis by Technology

    5.6. Disease Prevalence & Incidence Rate

6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Product, 2017-2027 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2027

        6.3.1. Analyzers

        6.3.2. Kits & Reagents

    6.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Product 

7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Technology, 2017-2027 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017–2027

        7.3.1. ELISA

        7.3.2. CLIA

        7.3.3. Others

    7.4.  Market Attractiveness, by Technology 

8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017–2027

        8.3.1. Hospitals

        8.3.2. Diagnostics Labs

        8.3.3. Blood Banks

        8.3.4. Others

    8.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by End-user

9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Region, 2017-2027

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Region

10. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027

        10.2.1. Analyzers

        10.2.2. Kits & Reagents

    10.3. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

        10.3.1. ELISA

        10.3.2. CLIA

        10.3.3. Others

    10.4. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

        10.4.1. Hospitals

        10.4.2. Diagnostics Labs

        10.4.3. Blood Banks

        10.4.4. Others

    10.5. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Country, 2017-2027 

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis 

        10.6.1. By Product 

        10.6.2. By Technology 

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

    11.1. Introduction

        11.1.1. Key Finding

    11.2. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

        11.2.1. Analyzers

        11.2.2. Kits & Reagents 

    11.3. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

        11.3.1. ELISA

        11.3.2. CLIA

        11.3.3. Others

    11.4. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

        11.4.1. Hospitals

        11.4.2. Diagnostic Labs

        11.4.3. Blood Banks

        11.4.4. Others

    11.5. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Russia

        11.5.7. Turkey

        11.5.8. Eastern Europe

        11.5.9. Rest of Europe

    11.6. Europe Syphilis Immunoassay Diagnostics Market Attractiveness Analysis 

        11.6.1. By Product 

        11.6.2. By Technology 

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

    12.1. Introduction

        12.1.1. Key Finding

    12.2. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

        12.2.1. Analyzers

        12.2.2. Kits & Reagents 

    12.3. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

        12.3.1. ELISA

        12.3.2. CLIA

        12.3.3. Others

    12.4. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

        12.4.1. Hospitals

        12.4.2. Diagnostic Labs

        12.4.3. Blood Banks

        12.4.4. Others

    12.5. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. South Korea

        12.5.6. Vietnam

        12.5.7. Rest of Asia Pacific

    12.6. Asia Pacific Syphilis Immunoassay Diagnostics Market Attractiveness Analysis 

        12.6.1. By Product 

        12.6.2. By Technology 

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

    13.1. Introduction

        13.1.1. Key Finding

    13.2. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

        13.2.1. Analyzers

        13.2.2. Kits & Reagents

    13.3. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

        13.3.1. ELISA

        13.3.2. CLIA

        13.3.3. Others

    13.4. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

        13.4.1. Hospitals

        13.4.2. Diagnostic Labs

        13.4.3. Blood Banks

        13.4.4. Others

    13.5. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Argentina

        13.5.4. Rest of Latin America

    13.6. Latin America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis 

        13.6.1. By Product 

        13.6.2. By Technology 

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

    14.1. Introduction

        14.1.1. Key Finding

    14.2. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

        14.2.1. Analyzers

        14.2.2. Kits & Reagents

    14.3. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

        14.3.1. ELISA

        14.3.2. CLIA

        14.3.3. Others

    14.4. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

        14.4.1. Hospitals

        14.4.2. Diagnostic Labs

        14.4.3. Blood Banks

        14.4.4. Others

    14.5. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Maghreb

        14.5.4. Rest of Middle East & Africa

    14.6. Middle East & Africa Syphilis Immunoassay Diagnostics Market Attractiveness Analysis 

        14.6.1. By Product 

        14.6.2. By Technology 

        14.6.3. By End-users

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis by Company (2018)

    15.3. Company Profiles

        15.3.1. F. Hoffmann-La Roche AG

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Company Financials

                15.3.1.3. Growth Strategies

                15.3.1.4. SWOT Analysis

        15.3.2. Bio-Rad Laboratories, Inc.

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Company Financials

                15.3.2.3. Growth Strategies

                15.3.2.4. SWOT Analysis

        15.3.3. BD

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Company Financials

                15.3.3.3. Growth Strategies

                15.3.3.4. SWOT Analysis

        15.3.4. Siemens Healthineers AG

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Company Financials

                15.3.4.3. Growth Strategies

                15.3.4.4. SWOT Analysis

        15.3.5. DiaSorin S.p.A.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Company Financials

                15.3.5.3. Growth Strategies

                15.3.5.4. SWOT Analysis

        15.3.6. Abbott

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Company Financials

                15.3.6.3. Growth Strategies

                15.3.6.4. SWOT Analysis

        15.3.7. Ortho Clinical Diagnostics (a part of Carlyle Group)

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Company Financials

                15.3.7.3. Growth Strategies

                15.3.7.4. SWOT Analysis

        15.3.8. Shenzhen New Industries Biomedical Engineering Co., Ltd.

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Company Financials

                15.3.8.3. Growth Strategies

                15.3.8.4. SWOT Analysis

        15.3.9. bioMérieux SA

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Company Financials

                15.3.9.3. Growth Strategies

                15.3.9.4. SWOT Analysis

        15.3.10. Fujirebio (Miraca Group) (Miraca Group)

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Company Financials

                15.3.10.3. Growth Strategies

                15.3.10.4. SWOT Analysis

        15.3.11. Fujirebio (Miraca Group)

                15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.11.2. Company Financials

                15.3.11.3. Growth Strategies

                15.3.11.4. SWOT Analysis

        15.3.12. Danaher (Beckman Coulter, Inc.)

                15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.12.2. Company Financials

                15.3.12.3. Growth Strategies

                15.3.12.4. SWOT Analysis

List of Tables

Table 01: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 02: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 04: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017 - 2027

Table 05: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017 - 2027

Table 06: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 07: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 08: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 09: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 10: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 11: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 12: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 13: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 14: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 15: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 16: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 17: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 18: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 19: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 20: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 21: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 22: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 23: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 24: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast,

List of Figures

Figure 01: Global Syphilis Diagnostics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Market Opportunity Map, by Product, 2018

Figure 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027

Figure 04: Global Syphilis Diagnostics Market Value Share, by Product, 2018

Figure 05: Global Syphilis Diagnostics Market Value Share, by Technology, 2018

Figure 06: Global Syphilis Diagnostics Market Value Share, by End-user, 2018

Figure 07: Global Syphilis Diagnostics Market Value Share, by Region, 2018

Figure 08: Global Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 09: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Analyzers, 2017 - 2027

Figure 10: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Kits & Reagents, 2017 - 2027

Figure 11: Global Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027

Figure 12: Global Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

Figure 13: Global Syphilis Diagnostics Market Value (US$ Mn), by ELISA Test, 2017 - 2027

Figure 14: Global Syphilis Diagnostics Market Value (US$ Mn), by CLIA Test, 2017 - 2027

Figure 15: Global Syphilis Diagnostics Market Value (US$ Mn), by Others, 2017 - 2027

Figure 16: Global Syphilis Diagnostics Market Attractiveness, by Technology, 2019 - 2027

Figure 17: Global Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 18: Global Syphilis Diagnostics Market Value (US$ Mn), by Hospitals, 2017 - 2027

Figure 19: Global Syphilis Diagnostics Market Value (US$ Mn), by Diagnostic Labs, 2017 - 2027

Figure 20: Global Syphilis Diagnostics Market Value (US$ Mn), by Blood Banks, 2017 - 2027

Figure 21: Global Syphilis Diagnostics Market Value (US$ Mn), by Others, 2017 - 2027

Figure 22: Global Syphilis Diagnostics Market Attractiveness, by End-user, 2019 - 2027

Figure 23: Global Syphilis Diagnostics Market Value Share Analysis, by Region, 2018 and 2027

Figure 24: Global Syphilis Diagnostics Market Attractiveness Analysis, by Region, 2019 - 2027

Figure 25: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027

Figure 26: North America Syphilis Diagnostics Market Attractiveness Analysis, by Country, 2019 - 2027

Figure 27: North America Syphilis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

Figure 28: North America Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 29: North America Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

Figure 30: North America Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 31: North America Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027

Figure 32: North America Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027

Figure 33: North America Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027

Figure 34: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027

Figure 35: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027

Figure 36: Europe Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 37: Europe Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 38: Europe Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

Figure 39: Europe Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 40: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027

Figure 41: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027

Figure 42: Europe Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027

Figure 43: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027

Figure 44: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027

Figure 45: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 47: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

Figure 48: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 49: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027

Figure 50: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027

Figure 51: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027

Figure 52: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027

Figure 53: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027

Figure 54: Latin America Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 55: Latin America Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 56: Latin America Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

Figure 57: Latin America Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 58: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027

Figure 59: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027

Figure 60: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027

Figure 61: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027

Figure 62: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027

Figure 63: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 65: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

Figure 66: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 67: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027

Figure 68: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027

Figure 69: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027

Figure 70: Danaher Diagnostics Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 71: R&D Intensity (US$ Mn), Diagnostics Business Segment, 2015–2017

Figure 72: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Region, 2018

Figure 73: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Product, 2018

Figure 74: Becton, Dickinson. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 75: Becton, Dickinson. Breakdown of Net Sales (%), by Region/Country, 2018

Figure 76: Becton, Dickinson. Revenue Breakdown of Net Sales (%), by Business Segment, 2018

Figure 77: Becton, Dickinson. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 78: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 79: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 80: Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 81: Breakdown of Net Sales (% Share), by Region, 2018

Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 83: R&D Expenses (US$ Mn), 2015 - 2018

Figure 84: Breakdown of Net Sales (% Share), by Business Segment (2018)

Figure 85: Breakdown of Net Sales (% Share), by Region (2018)

Figure 86: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 87: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 88: Breakdown of Net Sales (%), by Business Segment, 2018

Figure 89: Breakdown of Net Sales (%), by Region/Country, 2018

Figure 90: DiaSorin S.p.A. Revenue (US$ Mn), 2015 - 2018

Figure 91: DiaSorin S.p.A. R&D Expenses (US$ Mn), 2015 - 2018

Figure 92: DiaSorin S.p.A. Sales and Marketing Expenses (US$ Mn, 2015 - 2018

Figure 93: DiaSorin S.p.A. Breakdown of Net Sales (%), by Region, 2018

Figure 94: DiaSorin S.p.A. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 95: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 96: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 97: Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 98: Breakdown of Net Sales (% Share), by Region, 2018

Figure 99: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 100: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 101: Breakdown of Net Sales (% Share), by Application, 2018

Figure 102: Breakdown of Net Sales (% Share), by Region, 2018

Figure 103: Miraca Group (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Figure 104: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

553

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved